Advertisement

The Latest

Kansas City-based University of Kansas Cancer Center has launched the Center for Survivorship and Patient-Oriented Research as part of an initiative to improve not only cancer survival rates, but cancer survivor quality of life.

New York City-based NYU Langone has named Shridar Ganesan, MD, PhD, as director of the Perlmutter Cancer Center's new Center for Molecular Oncology. In collaboration with teams across NYU Langone, Dr. Ganesan will lead integration of genomic sequencing to personalize…

Houston-based University of Texas MD Anderson Cancer Center has partnered with the Union for International Cancer Control to address breast and cervical cancer on a global scale. 

Cancer survival among young adults has increased since the ACA's Dependent Care Expansion passed in 2010, allowing Americans to stay on their parents' health insurance plans until turning 26 years old, according to a study published Oct. 7 in Cancer. 

Los Angeles-based Cedars-Sinai is participating in the National Cancer Institute's first long-term national study of cancer among Asian Americans. Led by the University of California San Francisco, the study aims to learn why Asian Americans experience higher rates of cancer…

Advancements in immunotherapy and personalized medicine have pushed the oncology field forward, according to leaders from MD Anderson and City of Hope who shared their insights with Becker's.

The U.S. spent $99 billion on both oral and clinician-administered cancer therapies in 2023, according to a report published in April by analytics firm IQVIA. As cancer drug prices continue to increase, spending is projected to grow.

Advertisement